Search results for PX-TA1334

Showing 1 – 10 of1products
Lifastuzumab Biosimilar – Anti-SLC34A2 mAb – Research Grade Brand Logo
ID: BAB492999093

Lifastuzumab Biosimilar – Anti-SLC34A2 mAb – Research Grade, ProteoGenix, PX-TA1334

Description of Lifastuzumab Biosimilar - Anti-SLC34A2 mAb - Research Grade General information on Anti-SLC34A2[Homo sapiens] (Lifastuzumab) Monoclonal Antibody Lifastuzumab is investigated for the treatment of Non-Small Cell Lung Cancer (NSCLC) and Platinum Resistant Ovarian Cancer.

Host

Reactivity

Applications

Conjugation

Request a product

Please provide the required information below so that we can quickly source your products.